Hiroaki Semba

Cardiovascular Institute Hospital

Papers

1

Total Citations

1

H-Index

1

About

Dr. Hiroaki Semba is a leading researcher in parasitology, with a focused expertise on protozoan parasites that pose significant threats to human and animal health. His work centers on the molecular biology and high-throughput screening of key enzymes in *Toxoplasma gondii* and *Neospora caninum*, two major pathogens responsible for toxoplasmosis and neosporosis, respectively. Dr. Semba’s major contribution includes the development of a novel, robot-arm-assisted assay for nucleoside triphosphate hydrolases, enabling rapid, high-throughput screening of potential therapeutic compounds. This innovative approach directly addresses the urgent need for new treatments, particularly for immunocompromised patients—such as those with HIV or organ transplants—and pregnant women, where *T. gondii* can cause severe complications. While his most cited paper (2022) has garnered 1 citation to date, its methodological impact is poised to grow as it provides a scalable platform for drug discovery against these neglected parasitic diseases. Dr. Semba’s work bridges cutting-edge automation with fundamental parasitology, offering a promising pathway toward combating infections that affect millions globally.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Nucleoside Triphosphate Hydrolases Assay in <em>Toxoplasm gondii</em> and <em>Neospora caninum</em> for High-Throughput Screening using a Robot Arm
1 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Cardiovascular Institute Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago